Enalaprilat functions as a postoperative hypertension controller and demonstrates antiviral activity by inhibiting the interaction of ACE2 (Angiotensin converting enzyme 2) and the SARS-CoV-2 spike protein [10]. The gene discussed is ACE2; the disease is hypertensive disorder.